MARIA PHILLIPS: Open Payments
NPI 1669007282 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,689 in 104 payments from 15 companies in 2025. Trend: 2023 $1,515 · 2024 $1,707 · 2025 $1,689
Food & beverage: $1,689
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $367 |
| PFIZER INC. | 22 | $267 |
| Novo Nordisk Inc | 11 | $234 |
| AstraZeneca Pharmaceuticals LP | 12 | $210 |
| Lilly USA, LLC | 12 | $148 |
| Boston Scientific Corporation | 1 | $123 |
| Medtronic, Inc. | 3 | $74 |
| Lundbeck LLC | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Corcept Therapeutics | 2 | $45 |
Products named: VRAYLAR, MOUNJARO, LUX-Dx Insertable Cardiac Monitor, Rybelsus, FARXIGA, Ozempic, PREVNAR 20, REXULTI.
Industry payments across VA — which companies pay providers there.
